Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia
Top Cited Papers
- 4 July 2024
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 144 (1) , 99-112
Abstract
Platelet α-granules are rich in transforming growth factor β1 (TGF-β1), which is associated with myeloid-derived suppressor cell (MDSC) biology. Responders to thrombopoietin receptor agonists (TPO-RAs) revealed a parallel increase in the number of both platelets and MDSCs. Here, anti-CD61 immune-sensitized splenocytes were transferred into severe combined immunodeficient mice to establish an active murine model of immune thrombocytopenia (ITP). Subsequently, we demonstrated that TPO-RAs augmented the inhibitory activities of MDSCs by arresting plasma cells differentiation, reducing Fas ligand expression on cytotoxic T cells, and rebalancing T-cell subsets. Mechanistically, transcriptome analysis confirmed the participation of TGF-β/Smad pathways in TPO-RA–corrected MDSCs, which was offset by Smad2/3 knockdown. In platelet TGF-β1–deficient mice, TPO-RA-induced amplification and enhanced suppressive capacity of MDSCs was waived. Furthermore, our retrospective data revealed that patients with ITP achieving complete platelet response showed superior long-term outcomes compared with those who only reach partial response. In conclusion, we demonstrate that platelet TGF-β1 induces the expansion and functional reprogramming of MDSCs via the TGF-β/Smad pathway. These data indicate that platelet recovery not only serves as an end point of treatment response but also paves the way for immune homeostasis in immune-mediated thrombocytopenia.Keywords
This publication has 78 references indexed in Scilit:
- Fatal outcome of severe fever with thrombocytopenia syndrome (SFTS) and severe and critical COVID‐19 is associated with the hyperproduction of IL‐10 and IL‐6 and the low production of TGF‐βJournal of Medical Virology, 2023
- Stable CAD patients show higher levels of platelet-borne TGF-β1 associated with a superior pro-inflammatory state than the pro-aggregatory status; Evidence highlighting the importance of platelet-derived TGF-β1 in atherosclerosisJournal of Thrombosis and Thrombolysis, 2022
- Platelets fine-tune effector responses of naïve CD4+ T cells via platelet factor 4-regulated transforming growth factor β signalingCellular and Molecular Life Sciences, 2022
- Decreased levels of immune-regulatory cytokines in patients with immune thrombocytopenia and long-lasting overexpression of these cytokines in the splenectomized patientsJournal of Leukocyte Biology, 2021
- Role of Myeloid-derived suppressor cell (MDSC) in autoimmunity and its potential as a therapeutic targetInflammopharmacology, 2021
- Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primatesCancer Immunology, Immunotherapy, 2019
- Megakaryocytes as immune cellsJournal of Leukocyte Biology, 2019
- How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutionsCancer Immunology, Immunotherapy, 2018
- Induction of immune tolerance to platelet antigen by short-term thrombopoietin treatment in a mouse model of immune thrombocytopeniaInternational Journal of Hematology, 2014
- A transforming growth factor-β1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpuraAnnals of Hematology, 2000